OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category

Retrieved on: 2025-03-21 17:52:42

Tags for this article:

Gene delivery

Molecular genetics

Applied genetics

Biotechnology

Medical genetics

Contract manufacturing organization

Viral vector

Gene therapy

Adeno-associated virus

OXB

Virus

United Kingdom

Click the tags to see associated articles and topics

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category. View article details on hiswai:

Summary

OXB, a leading UK-based biopharma CDMO, was honored at the 2025 CDMO Leadership Awards for excellence in cell and gene therapy. Utilizing innovative viral vector technologies like adeno-associated virus, OXB supports global gene delivery projects.

Article found on: www.marketscreener.com

View Original Article